Referenzen
Produkte Transfektion
Kostenlose Testsamples
Anwendungshinweise:
Im „Transfection Reagent Selection Guide“ können Sie durch Filterfunktionen z.B. für Ihre Kombination aus zu transfizierender Zelle und Nukleinsäure die Liste vorhandener Referenzen durchsuchen. Ebenso können Sie im Feld „Referenzen durchsuchen“ am Anfang der Seite mit passenden Schlagwörtern zu einem Ergebnis gelangen. Eine Referenz zeigt an, dass das gefundene Transfektionsreagenz bereits erfolgreich für die entsprechende Anwendung verwendet wurde. Im Idealfall sind getestete Transfektionsparameter und Transfektionseffizienzen angegeben.
Keine Referenz? > Allgemeine Auswahlhilfe
Wenn Sie keine Referenz gefunden haben, heißt das nicht, dass kein passendes Reagenz zur Verfügung steht, sondern lediglich, dass bisher keine Erfahrungsberichte vorliegen. In diesem Falle kann durch eine Vorauswahl ein erfolgsversprechendes Transfektionsreagenz ausgewählt (Allgemeine Auswahlhilfe) und letztendlich ausgetestet (Kostenlose Testsamples) werden. Wenn Sie einen Erfahrungsbericht für uns schreiben möchten machen wir Ihnen ein Angebot für eine Gegenleistung.
CELL TYPE | DESCRIPTION OF CELL TYPE | CAT.NO. | SPECIES | ORIGIN OF CELLS | COMMON CELL TYPE | GROWTH PROPERTIES | NUCLEIC ACID / DELIVERED MOLECULE | APPLICATION | PRODUCT | REFERENCE TYPE | BIBLIOGRAPHIC DATA | LINK | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Human keratinocytes isolated from neonatal foreskin | Human | skin | primary cell | adherent | siRNA | RNA-Interference | Metafectene | publication | S. Bruche, PhD Thesis, 2014, Imperial College London | Link | |||
Human primary skin fibroblasts | Human | skin | primary cell | adherent | siRNA | RNA-Interference | Metafectene | publication | M. Milani et al., ResearchSquare, 2021, doi.org/10.21203/rs.3.rs-138253/v1 | Link | |||
Human primary chronic lymphocytic leukemia cells | Human | immune system | primary cell | suspension | siRNA | RNA-Interference | Metafectene | publication | S. Romano et al., Haematologica, Jul 2008; 93: 1039 - 1048 | Link | |||
Human primary fibroblasts (derived from ALS patients) | Human | unknown | cell line | adherent | siRNA | RNA-Interference | Metafectene | publication | M. Milani et al., J. of Neuroinflammation, 2021, 18: 132, doi.org/10.1186/s12974-021-02184-1 | Link | |||
Human primary fibroblasts | Human | unknown | primary cell | siRNA | RNA-Interference | Metafectene | publication | L. Woodbine et al., Nucleic Acids Res., Sep 2011; 39: 6986 - 6997 | Link | ||||
1BR3hTERT |
Human hTERT immortalized fibroblasts | Human | unknown | unknown | adherent | siRNA | RNA-Interference | Metafectene | publication | T. Stiff et al., Hum. Mol. Genet., Apr 2016; 25: 1574 - 1587 | Link | ||
293A |
Human embryonic kidney adenovirus producer cell line (derivat of HEK293) | DSM ACC 305 | Human | urinary system | cell line | adherent | siRNA | RNA-Interference | Metafectene | publication | W. Kim et al., J. Biol. Chem., 287 (8): 5278–5289, DOI 10.1074/jbc.M111.281709 | Link | |
293T |
Human embryonic kidney cell line, SV40 large T antigen inserted | ATCC CRL-3216 | Human | urinary system | cell line | adherent | siRNA | RNA-Interference | Metafectene | publication | T.-D. Kim et al., Mol. Cell. Biol., Apr 2005; 25: 3232 - 3246 | Link | |
293T |
Human embryonic kidney cell line, SV40 large T antigen inserted | ATCC CRL-3216 | Human | urinary system | cell line | adherent | siRNA | RNA-Interference | Metafectene | publication | K.-C. Woo et al., FASEB J, Aug 2011; 25: 2757 - 2769 | Link | |
293T |
Human embryonic kidney cell line, SV40 large T antigen inserted | ATCC CRL-3216 | Human | urinary system | cell line | adherent | siRNA | RNA-Interference | Metafectene | publication | D. Konina et al., Int. J. Mol. Sci., 2021, 22, 8477, doi.org/10.3390/ijms22168477 | Link | |
A375 |
Human skin malignant melanoma cell line | ATCC CRL-1619 | Human | skin | cell line | adherent | siRNA | RNA-Interference | Metafectene | publication | D. Konina et al., Int. J. Mol. Sci., 2021, 22, 8477, doi.org/10.3390/ijms22168477 | Link | |
A375 |
Human skin malignant melanoma cell line | ATCC CRL-1619 | Human | skin | cell line | adherent | siRNA | RNA-Interference | Metafectene | publication | S. Romano et al., Clinical and Translational Medicine, 2014, 3:1, doi:10.1186/2001-1326-3-1 | Link | |
A375 |
Human skin malignant melanoma cell line | ATCC CRL-1619 | Human | skin | cell line | adherent | siRNA | RNA-Interference | Metafectene | publication | S. Romano et al., Pigment Cell Melanoma Res., 2013, 26: 900–911, doi: 10.1111/pcmr.12144 | ||
A375 |
Human skin malignant melanoma cell line | ATCC CRL-1619 | Human | skin | cell line | adherent | siRNA | RNA-Interference | Metafectene | publication | D. O. Konina et al., BMC Genomics, 2019, 20 Suppl 3: 298, doi.org/10.1186/s12864-019-5538-z | Link | |
A549 |
Human lung alveolar epithelial adenocarcinoma carcinoma cell line | ATCC CCL-185 | Human | respiratory system | cell line | adherent | siRNA | RNA-Interference | Metafectene | publication | S.-E. Cheng et al., PLoS ONE, 2013, 8(1): e54125. doi:10.1371/journal.pone.0054125 | Link | |
A549 |
Human lung alveolar epithelial adenocarcinoma carcinoma cell line | ATCC CCL-185 | Human | respiratory system | cell line | adherent | siRNA | RNA-Interference | Metafectene | publication | W. Kim et al., J. Biol. Chem., 287 (8): 5278–5289, DOI 10.1074/jbc.M111.281709 | Link | |
A549 |
Human lung alveolar epithelial adenocarcinoma carcinoma cell line | ATCC CCL-185 | Human | respiratory system | cell line | adherent | siRNA | RNA-Interference | Metafectene | publication | P.-S. Hsu et al., Int. J. Mol. Sci., 2015, 16: 27640-27658; doi:10.3390/ijms161126045 | Link | |
A549 |
Human lung alveolar epithelial adenocarcinoma carcinoma cell line | ATCC CCL-185 | Human | respiratory system | cell line | adherent | siRNA | RNA-Interference | Metafectene | publication | I-T. Lee et al., J. of Nutritional Biochemistry, 2013, 24: 124–136, doi.org/10.1016/j.jnutbio.2012.03.009 | ||
A549 |
Human lung alveolar epithelial adenocarcinoma carcinoma cell line | ATCC CCL-185 | Human | respiratory system | cell line | adherent | siRNA | RNA-Interference | Metafectene | publication | M.-J. Kim et al., Cancer Letters, 2013, 339: 15–24, doi.org/10.1016/j.canlet.2013.07.027 | Link | |
A549 |
Human lung alveolar epithelial adenocarcinoma carcinoma cell line | ATCC CCL-185 | Human | respiratory system | cell line | adherent | siRNA | RNA-Interference | Metafectene | publication | C.-C. Lin et al., Am J Physiol Lung Cell Mol Physiol, Sep 2012; 303: L401 - L412 | ||
AGS |
Human gastric adenocarcinoma cell line | ATCC CRL-1739 | Human | digestive organs | cell line | adherent | siRNA | RNA-Interference | Metafectene | publication | A. Rocco, et al., Lab. Investigation, 2012, 92: 1407–1418, doi:10.1038/labinvest.2012.100 | Link | |
BT-20 |
Human breast cancer cell line | ATCC HTB-19 | Human | breast | cell line | adherent | siRNA | RNA-Interference | Metafectene | publication | M. Endres et al., Oncotarget, 2016, 7(39): 64244-64259 | Link | |
C4-2 |
Human prostate carcinoma cell line (derivat of LNCaP) | Human | genital tract | cell line | adherent | siRNA | RNA-Interference | Metafectene | publication | K. S. R. Sastry et al., J. Biol. Chem., Jul 2006; 281: 20891 - 20901 | Link | ||
CAF |
Human carcinoma associated fibroblasts | Human | digestive organs | primary cell | adherent | siRNA | RNA-Interference | Metafectene | publication | A. Min et al., J. Biochem. Molecular Toxicology, 2015, 29(2): 70-76; DOI 10.1002/jbt | |||
CCD 841 CoTr |
Human normal colon epithel cell line | ATCC CRL-1807 | Human | digestive organs | cell line | adherent | siRNA | RNA-Interference | Metafectene | publication | L. M. Williams, Dissertation, 2014, Royal College of Surgeons in Ireland | Link |